Supporting paid subscribers
I need to transition to support paid subscribers now. It’s coming up to 9 months since I’ve been publishing INSIDE PHARMA, and nearly all the Newsletters have been free.
This is because I have not wanted to restrict access to the stuff I know, as there is probably no one else with the depth and breadth of knowledge of clinical trial and commercial operations and supply chain management. We mustn't forget that the product of the manufacturing and distribution supply chain goes into the patients body, so it's crucial.
When Fauci says “follow the science”, he wants to make you believe drugs can be cooked up in a laboratory in a matter of months. That's pure smoke and mirrors.
I've reduced the annual payment
On the advice of one thoughtful subscriber, the annual payment is now reduced from $60 to $40. That makes it a tad over $3 a month, with me resisting the temptation to play the ‘cost of a coffee' card.
Substack doesn't let you go below $5 for a monthly subscrip…